Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
about
The neural control of micturitionBotulinum toxin A for the Treatment of Overactive BladderResearch Findings on Overactive BladderThe purinergic neurotransmitter revisited: a single substance or multiple players?The concept of peripheral modulation of bladder sensationA healthy bladder: a consensus statementThe pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseaseRelease of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretchEffectiveness of combined high-dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy.Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats.Immunocytochemical characterisation of cultures of human bladder mucosal cellsExpression and distribution of ectonucleotidases in mouse urinary bladder.beta-NAD is a novel nucleotide released on stimulation of nerve terminals in human urinary bladder detrusor muscle.ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling.The Role of the Mucosa in Normal and Abnormal Bladder Function.Effects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat.Aging differentially modifies agonist-evoked mouse detrusor contraction and calcium signals.Non-neuronal acetylcholine and urinary bladder urothelium.Role of Purinergic Signaling in Voiding Dysfunction.Muscarinic regulation of neonatal rat bladder spontaneous contractions.Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.Excitatory and Inhibitory Influence of Pathways in the Pelvic Nerve on Bladder Activity in Rats with Bladder Outlet ObstructionControl of urinary drainage and voiding.Purinoceptors as therapeutic targets for lower urinary tract dysfunction.Integrated control of lower urinary tract--clinical perspectiveIntegrative control of the lower urinary tract: preclinical perspectiveMuscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderPathophysiology and animal modeling of underactive bladder.Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking MrasThe localization of cyclo-oxygenase immuno-reactivity (COX I-IR) to the urothelium and to interstitial cells in the bladder wall.Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured ratsPurinergic signalling during development and ageing.The efficacy of different doses of solifenacin in elderly patients after treating a urinary tract infection.Afferent nerve regulation of bladder function in health and disease.Impairment of ATP hydrolysis decreases adenosine A1 receptor tonus favoring cholinergic nerve hyperactivity in the obstructed human urinary bladder.The emergence of new drugs for overactive bladder.Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?Overactive bladder syndrome in older people.Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.
P2860
Q24619130-6812CB51-52F1-4244-9725-CF618471705BQ26764765-36E86248-F8C0-4320-BA6B-72091D2448E4Q26801459-616198C4-63D5-4F8D-82FE-E68CDFA519C4Q26824817-C2838A76-FB3F-42F1-BD1F-06CD582E4D7EQ26825508-222B346F-6791-48E9-9D50-44361F4CF0A6Q26863299-48582FD8-75A0-44A7-B0DC-A0B49B3D4E1DQ26864937-318F4E2C-1B0F-4547-B519-E62C96933645Q33569495-BDDC6427-2664-4F0D-81BA-D79A48B50427Q33819939-F7F88BD8-758C-4F5E-9EDE-63496E24B0B4Q33853947-99145B3F-6B3A-47A9-B6C6-630A981062CBQ33874538-C98D434F-2BDD-45F6-95F1-EF51970EA6ACQ33886615-81E7D3B9-35BD-49B9-B54C-B00BA9C563C2Q33990341-89ABC9EF-8F42-4F2F-940A-8253BF59F8F8Q34512888-1C27966E-02FE-4E6B-BF2E-E2423DE8E646Q34528370-44E8141B-A4B8-4A31-AEB1-D7EDD5D1E573Q34554749-2A9D81E4-4CBB-4833-8DE3-459B8557D141Q34714783-C0799909-9A3F-4061-AC71-AA462B524F38Q34903817-A1DC3A84-451D-4E72-B49A-D7B4C16EF467Q34973917-D02217DF-2786-48EA-A912-52D5465A6BA0Q35037138-DA6F56E6-EB70-4145-9E81-11E3B1824B51Q35048803-E1842D9F-A30B-483B-9E68-12D436259120Q35058400-0DAC74D6-34FE-4AE5-8BEF-C393BFF39CFBQ35144401-5648B4FC-E8C4-447F-89EB-E1EEDA11D710Q35545723-1DEC43F0-E1C7-471A-AD71-F7FD851335B2Q35545736-DECE0916-9AF9-4856-A613-51432B141DE5Q35545750-99CAE395-02E0-4AA7-BEDE-5DFBA78E64E7Q35546189-31407BB5-26E1-49CB-A044-C8E0980D73DFQ35747930-243EF575-33A5-47DD-8614-73FF385E12D6Q35827050-2B419F8E-8C50-406C-8863-83EB13B46D38Q35893233-9C8449CB-B47D-491E-AD28-331B0981CC61Q35925893-C3AE9449-6B58-4E8E-B6E1-DAE9282EB6D4Q35930763-E9250806-5FE2-4919-B1CF-9D09E549A348Q36038099-6611260E-4778-44F5-BE30-1BDDD23FFB28Q36057867-2A2B5C08-3B4B-4B8B-B9E3-E2A16379605BQ36289463-F4447F29-1DAF-42D8-B70C-94A41B436F55Q36407417-8E561D82-32A1-4A3E-A54D-AA15FBF4A4D8Q36574048-80B32F5B-F99E-4B8E-8BF8-9ED2B137B8DCQ36735590-AF042F69-5D66-44D5-A4FA-FC56CD9D2685Q36779724-4AFAEB88-C3CD-4646-B6F6-BAEEA91CD53DQ36788773-44ED33CC-AB54-4E34-B8B9-0697079CE18C
P2860
Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Management of detrusor dysfunc ...... hosphate release during aging.
@ast
Management of detrusor dysfunc ...... hosphate release during aging.
@en
type
label
Management of detrusor dysfunc ...... hosphate release during aging.
@ast
Management of detrusor dysfunc ...... hosphate release during aging.
@en
prefLabel
Management of detrusor dysfunc ...... hosphate release during aging.
@ast
Management of detrusor dysfunc ...... hosphate release during aging.
@en
P2093
P1433
P1476
Management of detrusor dysfunc ...... hosphate release during aging.
@en
P2093
Akito Inadome
Hitoshi Iwashita
Koichi Miyamae
Masaki Yoshida
Masayuki Otani
P356
10.1016/J.UROLOGY.2003.11.003
P407
P433
P577
2004-03-01T00:00:00Z